Literature DB >> 19784699

Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent.

Jorge Martín1, Lisset Hermida, Jorge Castro, Yaremis Romero, Jane Cardosa, Gerardo Guillén.   

Abstract

Testing in non-human primates is a generally accepted necessary step preceding the evaluation of dengue vaccine candidates in humans. A reduction of viremia in these animals after virus challenge is generally used as an indicator of vaccine efficacy. In this work, we compared the infectivity of three strains of dengue virus type 2 in a non-human primate model of dengue infection, with the aim of selecting a virus for vaccine protection studies. As a result, strain SB8553 produced the longest duration of viremia, with a mean of 3 days/animal. In addition, it induced the highest antiviral and neutralizing antibody titers. These results support the use of strain SB8553 in challenge assays in this model and demonstrate that infection of green monkeys with dengue virus type 2 is dependent on the strain of virus used.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19784699     DOI： 10.1007/s00284-009-9488-6

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN： 0343-8651            Impact factor:   2.188


  10 in total

1.  Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever.

Authors:  V Churdboonchart; N Bhamarapravati; S Peampramprecha; S Sirinavin
Journal:  Am J Trop Med Hyg       Date:  1991-05       Impact factor: 2.345

2.  Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys.

Authors:  Patrick J Blair; Tadeusz J Kochel; Kanakatte Raviprakash; Carolina Guevara; Milagros Salazar; Shuenn-Jue Wu; James G Olson; Kevin R Porter
Journal:  Vaccine       Date:  2005-09-27       Impact factor: 3.641

3.  Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection.

Authors:  S B Halstead; H Shotwell; J Casals
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization.

Authors:  D M Morens; S B Halstead; P M Repik; R Putvatana; N Raybourne
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

5.  Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virus.

Authors:  Ann M Schiavetta; Joseph G Harre; Elizabeth Wagner; Monika Simmons; Kanakatte Raviprakash
Journal:  Contemp Top Lab Anim Sci       Date:  2003-09

6.  Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: a potential model for vaccine testing.

Authors:  Jorge Martín; Lisset Hermida; Jorge Castro; Laura Lazo; Rafael Martínez; Lázaro Gil; Yaremis Romero; Pedro Puente; Santiago Zaragoza; Karelia Cosme; Maria G Guzmán; Jane Cardosa; Gerardo Guillén
Journal:  Microbiol Immunol       Date:  2009-04       Impact factor: 1.955

7.  Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2.

Authors:  Lidice Bernardo; Alienys Izquierdo; Irina Prado; Delfina Rosario; Mayling Alvarez; Emidalys Santana; Jorge Castro; Rafael Martínez; Rosmari Rodríguez; Luis Morier; Gerardo Guillén; María G Guzmán
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

8.  Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis.

Authors:  Iris Valdés; Lisset Hermida; Jorge Martín; Tamara Menéndez; Lázaro Gil; Laura Lazo; Jorge Castro; Olivia Niebla; Carlos López; Lídice Bernardo; Jorge Sánchez; Yaremis Romero; Rafael Martínez; María G Guzmán; Gerardo Guillén
Journal:  Vaccine       Date:  2008-12-25       Impact factor: 3.641

9.  Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys.

Authors:  M S Freire; R S Marchevsky; L F C Almeida; A M Y Yamamura; E C Caride; P A Brindeiro; M C A Motta; R M R Nogueira; C F Kubelka; M C Bonaldo; R Galler
Journal:  Mem Inst Oswaldo Cruz       Date:  2007-05       Impact factor: 2.743

10.  Models of dengue virus infection.

Authors:  Dennis A Bente; Rebeca Rico-Hesse
Journal:  Drug Discov Today Dis Models       Date:  2006
  10 in total
  9 in total

1.  The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2.

Authors:  Iris Valdés; Lázaro Gil; Yaremis Romero; Jorge Castro; Pedro Puente; Laura Lazo; Ernesto Marcos; María G Guzmán; Gerardo Guillén; Lisset Hermida
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

Review 2.  The tortoise or the hare? Impacts of within-host dynamics on transmission success of arthropod-borne viruses.

Authors:  Benjamin M Althouse; Kathryn A Hanley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

Review 3.  Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis.

Authors:  Benjamin M Althouse; Anna P Durbin; Kathryn A Hanley; Scott B Halstead; Scott C Weaver; Derek A T Cummings
Journal:  Virology       Date:  2014-02-14       Impact factor: 3.616

Review 4.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

5.  Serotype-specific host responses in rhesus macaques after primary dengue challenge.

Authors:  Andrew C Hickey; Jacob A Koster; Claudia M Thalmann; Kathy Hardcastle; Phaik-Hooi Tio; Mary J Cardosa; Katharine N Bossart
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

6.  Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.

Authors:  Caitlin M Briggs; Katherine M Smith; Amanda Piper; Emerson Huitt; Carla J Spears; Michelle Quiles; Mariana Ribeiro; Malcolm E Thomas; Dennis T Brown; Raquel Hernandez
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

7.  Testing of novel dengue virus 2 vaccines in African green monkeys: safety, immunogenicity, and efficacy.

Authors:  Katherine M Smith; Kavita Nanda; Carla J Spears; Amanda Piper; Mariana Ribeiro; Michelle Quiles; Caitlin M Briggs; Gwynneth S Thomas; Malcolm E Thomas; Dennis T Brown; Raquel Hernandez; Victoria McCarl
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

8.  Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype.

Authors:  Katherine M Smith; Kavita Nanda; Carla J Spears; Mariana Ribeiro; Ricardo Vancini; Amanda Piper; Gwynneth S Thomas; Malcolm E Thomas; Dennis T Brown; Raquel Hernandez
Journal:  Virol J       Date:  2011-06-09       Impact factor: 4.099

9.  Natural exposure of horses to mosquito-borne flaviviruses in south-east Queensland, Australia.

Authors:  Natalie A Prow; Cindy S E Tan; Wenqi Wang; Jody Hobson-Peters; Lisa Kidd; Anita Barton; John Wright; Roy A Hall; Helle Bielefeldt-Ohmann
Journal:  Int J Environ Res Public Health       Date:  2013-09-17       Impact factor: 3.390
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.